Goldman Sachs’s Bausch Health BHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-250,000
| Closed | -$2M | – | 5544 |
|
|
2023
Q2 | $2M | Hold |
250,000
| – | – | ﹤0.01% | 3878 |
|
|
2023
Q1 | $2.02M | Buy |
+250,000
| New | +$2.01M | ﹤0.01% | 3854 |
|
|
2022
Q1 | – | Sell |
-176,700
| Closed | -$4.88M | – | 6571 |
|
|
2021
Q4 | $4.88M | Buy |
+176,700
| New | +$4.73M | ﹤0.01% | 3433 |
|
|
2021
Q2 | – | Sell |
-90,000
| Closed | -$2.86M | – | 6202 |
|
|
2021
Q1 | $2.86M | Buy |
+90,000
| New | +$2.64M | ﹤0.01% | 3629 |
|
|
2020
Q1 | – | Sell |
-7,100
| Closed | -$212K | – | 5208 |
|
|
2019
Q4 | $212K | Buy |
+7,100
| New | +$185K | ﹤0.01% | 4864 |
|
|
2019
Q3 | – | Sell |
-83,200
| Closed | -$2.1M | – | 5166 |
|
|
2019
Q2 | $2.1M | Buy |
83,200
+34,300
| +70% | +$814K | ﹤0.01% | 3508 |
|
|
2019
Q1 | $1.21M | Sell |
48,900
-19,000
| -28% | -$454K | ﹤0.01% | 3952 |
|
|
2018
Q4 | $1.25M | Sell |
67,900
-600,000
| -90% | -$14.3M | ﹤0.01% | 3837 |
|
|
2018
Q3 | $17.1M | Buy |
667,900
+600,000
| +884% | +$13.7M | ﹤0.01% | 2032 |
|
|
2018
Q2 | $1.58M | Sell |
67,900
-44,200
| -39% | -$914K | ﹤0.01% | 3780 |
|
|
2018
Q1 | $1.78M | Sell |
112,100
-481,400
| -81% | -$8.96M | ﹤0.01% | 3684 |
|
|
2017
Q4 | $12.3M | Sell |
593,500
-551,000
| -48% | -$8.74M | ﹤0.01% | 2296 |
|
|
2017
Q3 | $16.4M | Buy |
1,144,500
+4,200
| +0.4% | +$63.5K | ﹤0.01% | 2158 |
|
|
2017
Q2 | $19.7M | Buy |
1,140,300
+589,100
| +107% | +$7.06M | 0.01% | 1946 |
|
|
2017
Q1 | $6.08M | Sell |
551,200
-696,000
| -56% | -$9.57M | ﹤0.01% | 2781 |
|
|
2016
Q4 | $18.1M | Sell |
1,247,200
-737,400
| -37% | -$13.5M | 0.01% | 2029 |
|
|
2016
Q3 | $48.7M | Buy |
1,984,600
+740,200
| +59% | +$19.2M | 0.01% | 1227 |
|
|
2016
Q2 | $25.1M | Buy |
1,244,400
+72,400
| +6% | +$2.05M | 0.01% | 1624 |
|
|
2016
Q1 | $30.8M | Sell |
1,172,000
-1,635,600
| -58% | -$121M | 0.01% | 1404 |
|
|
2015
Q4 | $285M | Buy |
2,807,600
+2,348,400
| +511% | +$264M | 0.09% | 225 |
|
|
2015
Q3 | $81.9M | Buy |
459,200
+125,100
| +37% | +$29.2M | 0.03% | 740 |
|
|
2015
Q2 | $74.2M | Sell |
334,100
-118,400
| -26% | -$26.2M | 0.02% | 848 |
|
|
2015
Q1 | $89.9M | Sell |
452,500
-778,300
| -63% | -$138M | 0.03% | 704 |
|
|
2014
Q4 | $176M | Sell |
1,230,800
-18,500
| -1% | -$2.49M | 0.06% | 412 |
|
|
2014
Q3 | $164M | Sell |
1,249,300
-384,000
| -24% | -$45.8M | 0.05% | 421 |
|
|
2014
Q2 | $206M | Buy |
1,633,300
+699,500
| +75% | +$89.2M | 0.06% | 350 |
|
|
2014
Q1 | $123M | Sell |
933,800
-26,400
| -3% | -$3.61M | 0.04% | 527 |
|
|
2013
Q4 | $113M | Buy |
960,200
+701,300
| +271% | +$76.8M | 0.04% | 580 |
|
|
2013
Q3 | $27M | Buy |
258,900
+40,000
| +18% | +$3.9M | 0.01% | 1377 |
|
|
2013
Q2 | $18.8M | Buy |
+218,900
| New | +$17.2M | 0.01% | 1593 |
|
Other funds holding BHC
PC
GAM
VCM
MP
KKRC
Goldman Sachs's BHC Position: Q1 2026 in Review
Goldman Sachs increased its Bausch Health (BHC) stake by 1.3% in Q1 2026, buying an estimated $385K and bringing the position to 5,207,966 shares worth $28.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2116.
Goldman Sachs first reported a position in BHC in Q2 2013 and has held it in 52 quarters since. The position peaked at $591M in Q4 2015. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.
- Goldman Sachs held 5,207,966 shares of Bausch Health worth $28.1M as of Q1 2026.
- Goldman Sachs bought 64,325 Bausch Health shares in Q1 2026, an estimated $385K.
- Bausch Health made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #2116 holding.
- Goldman Sachs first reported a position in Bausch Health in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's Bausch Health position peaked at $591M in Q4 2015.
- 227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.